← Open Payments lookup

SUMAIRA AHMED: Open Payments

NPI 1043247687 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,494 in 65 payments from 12 companies in 2025. Trend: 2023 $1,025 · 2024 $1,593 · 2025 $1,494

Food & beverage: $1,494
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$286
Axsome Therapeutics, Inc.7$281
ABBVIE INC.14$255
Otsuka America Pharmaceutical, Inc.11$163
Janssen Pharmaceuticals, Inc4$121
Lundbeck LLC5$111
Neurocrine BioSciences, Inc.3$78
Teva Pharmaceuticals USA, Inc.4$76
Alkermes, Inc.2$48
Vanda Pharmaceuticals Inc.2$35

Products named: CAPLYTA, Auvelity, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, INVEGA SUSTENNA, INGREZZA, UZEDY.

Industry payments across TX — which companies pay providers there.